Abacus Planning Group, Inc. Edwards Lifesciences Corp Transaction History

Abacus Planning Group, Inc.

$545 Million
Q3 2024

A detailed history of Abacus Planning Group, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 40,067 shares of EW stock, worth $2.8 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

40,067

Previous 39,438 1.59%

Holding current value

$2.8 Million

Previous $3.64 Million 27.4%

% of portfolio

0.49%

Previous 0.72%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	BUY	$59.7 - $93.78 $37,551 - $58,987	629 Added 1.59%	40,067 $2.64 Million
Q2 2024 Jul 30, 2024	BUY	$84.3 - $94.31 $1,601 - $1,791	19 Added 0.05%	39,438 $3.64 Million
Q4 2023 Jan 19, 2024	SELL	$61.71 - $77.76 $4,813 - $6,065	-78 Reduced 0.2%	39,419 $3.01 Million
Q3 2023 Oct 11, 2023	BUY	$69.28 - $93.38 $5,403 - $7,283	78 Added 0.2%	39,497 $2.74 Million
Q2 2023 Jul 06, 2023	SELL	$81.41 - $94.33 $34,599 - $40,090	-425 Reduced 1.07%	39,419 $3.72 Million
Q1 2023 Apr 17, 2023	BUY	$74.26 - $84.51 $27,847 - $31,691	375 Added 0.95%	39,844 $3.3 Million
Q4 2022 Jan 19, 2023	SELL	$68.3 - $87.44 $41,184 - $52,726	-603 Reduced 1.5%	39,469 $0
Q3 2021 Oct 19, 2021	SELL	$102.91 - $122.75 $15,951 - $19,026	-155 Reduced 0.39%	40,072 $4.54 Million
Q2 2021 Jul 20, 2021	SELL	$83.84 - $104.76 $124,921 - $156,092	-1,490 Reduced 3.57%	40,227 $4.17 Million
Q1 2021 Apr 27, 2021	SELL	$78.68 - $90.67 $130,608 - $150,512	-1,660 Reduced 3.83%	41,717 $3.49 Million
Q3 2020 Nov 03, 2020	SELL	$67.19 - $87.44 $38,298 - $49,840	-570 Reduced 1.3%	43,377 $3.46 Million
Q2 2020 Aug 11, 2020	BUY	$57.54 - $76.95 $1.68 Million - $2.25 Million	29,276 Added 199.55%	43,947 $3.04 Million
Q1 2020 Apr 30, 2020	SELL	$52.41 - $81.0 $8,542 - $13,203	-163 Reduced 1.1%	14,671 $2.77 Million
Q4 2019 Jan 30, 2020	SELL	$71.7 - $82.09 $5,879 - $6,731	-82 Reduced 0.55%	14,834 $3.46 Million
Q3 2019 Nov 01, 2019	BUY	$61.55 - $75.43 $26,651 - $32,661	433 Added 2.99%	14,916 $3.28 Million
Q2 2019 Aug 12, 2019	SELL	$55.74 - $64.41 $848,920 - $980,964	-15,230 Closed	0 $0
Q1 2019 Apr 25, 2019	SELL	$47.89 - $64.05 $11,110 - $14,859	-232 Reduced 1.5%	15,230 $2.91 Million
Q4 2018 Feb 15, 2019	BUY	$46.41 - $56.94 $272,751 - $334,636	5,877 Added 61.31%	15,462 $2.37 Million
Q4 2018 Feb 14, 2019	BUY	$46.41 - $56.94 $444,839 - $545,769	9,585 New	9,585 $836,000
Q4 2018 Jan 25, 2019	SELL	$46.41 - $56.94 $6,033 - $7,402	-130 Reduced 0.83%	15,462 $2.37 Million
Q2 2018 Jul 27, 2018	SELL	$42.45 - $51.3 $24,833 - $30,010	-585 Reduced 3.62%	15,592 $2.27 Million
Q1 2018 May 04, 2018	SELL	$37.19 - $47.45 $2,491 - $3,179	-67 Reduced 0.41%	16,177 $2.26 Million
Q4 2017 Mar 06, 2018	BUY	$33.79 - $39.39 $548,884 - $639,851	16,244	16,244 $1.83 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

462M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.

Account

Abacus Planning Group, Inc. Edwards Lifesciences Corp Transaction History